Thyroid FNA: papillary on two passes

A thyroid fine-needle aspiration is a needle biopsy that pulls cells from a neck lump, and one two-pass case shared online came back malignant for papillary thyroid carcinoma. (thyroid.org) Doctors usually do the test with ultrasound, which works like live sonar to keep the needle inside the nodule while avoiding nearby structures in the neck. The American Thyroid Association says the procedure is typically done in an office setting and is generally simple and safe. (thyroid.org) The lab result in the posted case was Bethesda category VI, the top tier in the standard six-part thyroid cytology system. In Endotext’s summary of the Bethesda system, category VI carries an estimated malignancy risk of about 97% to 99% when noninvasive follicular thyroid neoplasm with papillary-like nuclear features is excluded. (ncbi.nlm.nih.gov) Papillary thyroid carcinoma is the most common thyroid cancer, and fine-needle aspiration is the main triage test used when ultrasound shows a nodule that may need sampling. The National Cancer Institute says thyroid nodules are common and usually not cancer, which is why the biopsy result matters more than the lump alone. (cancer.gov) The technical point in this case is the limited-pass approach: two passes, two needle sizes, and still enough material for a definitive call. Adequacy rules for thyroid smears usually ask for at least six groups of well-visualized follicular cells, but that minimum does not apply when the sample already shows clear atypia in Bethesda categories III through VI. (pathologyoutlines.com) Needle size is one of the variables operators debate. A 2024 prospective study of 177 nodules found higher adequacy with 23-gauge than 25-gauge needles, but a 2025 meta-analysis covering 16 studies and 3,438 nodules found no statistically significant adequacy difference between larger and smaller gauges overall. (pubmed.ncbi.nlm.nih.gov 1) (pubmed.ncbi.nlm.nih.gov 2) That split evidence helps explain why clinicians often choose gauge based on the nodule, their own technique, and how bloody or painful they expect the pass to be, rather than on one universal rule. The American Thyroid Association’s pathology quality review lists gauge size, ultrasound guidance, and operator skill among the factors that affect sample adequacy. (thyroid.org) In practice, a case like this shows what thyroid cytology is built to do: turn a few needle passes into a management decision that can move directly to surgery planning instead of repeat biopsy. For Bethesda VI, standard references link the diagnosis to operative management such as lobectomy or total thyroidectomy, depending on tumor size and spread. (ncbi.nlm.nih.gov)